SG11201607487UA - New markers for the assessment of the risk for development of a cardiovascular disorder - Google Patents

New markers for the assessment of the risk for development of a cardiovascular disorder

Info

Publication number
SG11201607487UA
SG11201607487UA SG11201607487UA SG11201607487UA SG11201607487UA SG 11201607487U A SG11201607487U A SG 11201607487UA SG 11201607487U A SG11201607487U A SG 11201607487UA SG 11201607487U A SG11201607487U A SG 11201607487UA SG 11201607487U A SG11201607487U A SG 11201607487UA
Authority
SG
Singapore
Prior art keywords
assessment
risk
development
cardiovascular disorder
new markers
Prior art date
Application number
SG11201607487UA
Inventor
Sybille Hess
Hertzel Gerstein
Guillaume Pare
Matthew Mcqueen
Original Assignee
Sanofi Aventis Deutschland
Univ Mcmaster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland, Univ Mcmaster filed Critical Sanofi Aventis Deutschland
Publication of SG11201607487UA publication Critical patent/SG11201607487UA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201607487UA 2014-03-21 2015-03-20 New markers for the assessment of the risk for development of a cardiovascular disorder SG11201607487UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14305406 2014-03-21
EP14306528 2014-09-30
PCT/EP2015/055981 WO2015140317A1 (en) 2014-03-21 2015-03-20 New markers for the assessment of the risk for development of a cardiovascular disorder

Publications (1)

Publication Number Publication Date
SG11201607487UA true SG11201607487UA (en) 2016-10-28

Family

ID=52692655

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607487UA SG11201607487UA (en) 2014-03-21 2015-03-20 New markers for the assessment of the risk for development of a cardiovascular disorder

Country Status (7)

Country Link
US (1) US20170138961A1 (en)
EP (2) EP3517964B1 (en)
CN (2) CN110161252B (en)
CA (1) CA2942848A1 (en)
IL (1) IL247831B (en)
SG (1) SG11201607487UA (en)
WO (1) WO2015140317A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
JP7438757B2 (en) * 2017-02-06 2024-02-27 バイオテンプト・ベー・フェー Peptide modulators of the interaction of human C-peptide and human elastin receptors for therapeutic applications
CN113238063A (en) * 2021-05-31 2021-08-10 迈克生物股份有限公司 Use of GDF15 to assess the progression of metabolic syndrome patients to cardiovascular disease
GB202117397D0 (en) * 2021-12-02 2022-01-19 Univ London Queen Mary Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20080118924A1 (en) * 2006-05-26 2008-05-22 Buechler Kenneth F Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
JP2012506537A (en) * 2008-10-21 2012-03-15 アスチュート メディカル,インコーポレイテッド Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102812359A (en) * 2009-11-13 2012-12-05 Bg医药公司 Risk Factors And Prediction Of Myocardial Infarction
CN103492590A (en) * 2011-02-22 2014-01-01 卡里斯生命科学卢森堡控股有限责任公司 Circulating biomarkers
EP2761289B1 (en) * 2011-09-30 2020-02-12 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
US9733261B2 (en) * 2012-04-24 2017-08-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
EP3152580B1 (en) * 2014-06-05 2019-10-16 Sanofi-Aventis Deutschland GmbH New markers for the assessment of an increased risk for mortality

Also Published As

Publication number Publication date
CA2942848A1 (en) 2015-09-24
CN107076755B (en) 2019-03-29
EP3517964A2 (en) 2019-07-31
CN110161252B (en) 2022-10-14
EP3517964B1 (en) 2022-04-13
CN110161252A (en) 2019-08-23
EP3517964A3 (en) 2019-08-14
CN107076755A (en) 2017-08-18
IL247831B (en) 2019-02-28
WO2015140317A1 (en) 2015-09-24
EP3120148A1 (en) 2017-01-25
EP3120148B1 (en) 2019-01-30
US20170138961A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
IL283670A (en) E-vaping cartridge
IL247926B (en) Nebulizer for a fluid
EP3154419A4 (en) Hazard based assessment patterns
AU359973S (en) A flask
HK1214981A1 (en) A micro-humidifier
AU358101S (en) Tape measure
GB201420908D0 (en) Biomarkers
GB201401603D0 (en) Biomarkers
ZA201607726B (en) Checking the authenticity of a balise
GB2528233B (en) Identifying features
PT3107946T (en) A polyiso-urea
GB2531324B (en) A stylus
PL3230481T3 (en) A ferritic alloy
GB201421060D0 (en) A winch
IL249322A0 (en) New markers for the assessment of an increased risk for mortality
GB201408653D0 (en) Moonpool
GB201404189D0 (en) Novel biomarkers
IL247831B (en) New markers for the assessment of the risk for development of a cardiovascular disorder
SG10201800570RA (en) Biomarkers for assessing hiv
SG11201607649XA (en) A dam
IL249239B (en) Fibrous tape
GB201413081D0 (en) Markers for AF
GB201415074D0 (en) Centre-tapped transformer
GB201402247D0 (en) A footgauge
GB2525027B (en) Marking gauge